⌘K

Login Start Free

Home/Insiders/Mazumdar-Shaw Kiran

MK

SEC Insider//CIK 0002034672

Mazumdar-Shaw Kiran

CIK 00020346721 companyBOSTON, MA

Transactions

10

Companies

1

Filings

2

CIK

0002034672

Recent Transactions

10 trades

Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-06-09+23,746→ 23,746 total
Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2024-09-16+4,327,365→ 4,443,122 total
Conversion
Bicara Therapeutics Inc.$BCAX
Series Seed Redeemable Convertible Preferred Stock
2024-09-16−3,000,000→ 0 total
Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2024-09-16+1,080,775→ 1,080,775 total
Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2024-09-16+324,552→ 324,552 total
Conversion
Bicara Therapeutics Inc.$BCAX
Series Seed Redeemable Convertible Preferred Stock
2024-09-16−40,000,000→ 0 total
Conversion
Bicara Therapeutics Inc.$BCAX
Series Seed Redeemable Convertible Preferred Stock
2024-09-16−9,990,144→ 0 total
Conversion
Bicara Therapeutics Inc.$BCAX
Series Seed Redeemable Convertible Preferred Stock
2024-09-16−4,000,000→ 0 total
Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2024-09-16+432,736→ 432,736 total
Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2024-09-12+23,746→ 23,746 total

Companies

1

Bicara Therapeutics Inc.
Director, 10% Owner
$BCAX

Recent Filings

2

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116

View on SEC.gov